Crossref
Stereotactic body radiotherapy in pancreatic ductal adenocarcinoma: interpreting the results of the SPAN-C trial
Annals of Pancreatic Cancer · 2026-05 · 9 · 8-8
DOI: 10.21037/apc-26-0018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Pancreatic Cancer, 2026-05. Verfasst von Jacobien C. M. Scheepens und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Scheepens, J. C. M., Grimbergen, G., & Daamen, L. A. (2026). Stereotactic body radiotherapy in pancreatic ductal adenocarcinoma: interpreting the results of the SPAN-C trial. Annals of Pancreatic Cancer, 9, 8-8. https://doi.org/10.21037/apc-26-0018
Vancouver
Scheepens JCM, Grimbergen G, Daamen LA. Stereotactic body radiotherapy in pancreatic ductal adenocarcinoma: interpreting the results of the SPAN-C trial. Annals of Pancreatic Cancer. 2026;9:8-8. doi:10.21037/apc-26-0018
BibTeX
@article{Scheepens2026,
author = {Scheepens, Jacobien C. M. and Grimbergen, Guus and Daamen, Lois A.},
title = {Stereotactic body radiotherapy in pancreatic ductal adenocarcinoma: interpreting the results of the SPAN-C trial},
journal = {Annals of Pancreatic Cancer},
year = {2026},
volume = {9},
pages = {8--8},
doi = {10.21037/apc-26-0018}
}
EUVIMED